NIH-funded research R21 grant

Understanding how a tick enzyme may trigger red-meat allergy

Official title: Understanding the Role of Tick Phospholipase A2 in Alpha-Gal Syndrome

Funded at University of Southern Mississippi · NIH-11377997 · Data updated 2026-11-12

A clinician-scientist aims to understand how a tick enzyme might push the immune system toward meat allergy in adults who develop Alpha Gal Syndrome after a tick bite.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Southern Mississippi
NIH-funded
Lab location1 site (Hattiesburg, United States)
Project startJuly 23, 2025
Project endJune 30, 2027
Funding year2026
Award (this year)$186,369
NIH project number5R21AI190957-02
Project IDNIH-11377997 on NIH RePORTER

Who could benefit from this research

Could help

Adults who have experienced or are at risk for Alpha Gal Syndrome and related meat-allergy symptoms may be relevant for future translational applications.

Less likely to help

People without AGS or without exposure to Am. americanum bites are unlikely to benefit directly.

What this research studies

This project looks at Alpha Gal Syndrome, a new food allergy linked to bites from lone star ticks. It investigates the role of a tick enzyme called phospholipase A2 in shaping the immune response that leads to allergy to red meat. The study will use laboratory and possibly patient-derived samples to explore how tick saliva could drive a Th2-skewed response and the presence of the α-gal sugar in foods. By clarifying these mechanisms, the work could point to better diagnostics and preventive strategies for AGS.

Why it matters

Potential benefit: If successful, the work could contribute to better tests and prevention methods for Alpha Gal Syndrome, potentially reducing allergy risk after tick bites.

How similar studies have gone: Previous work has linked tick bites to AGS and salivary enzymes to immune responses, but this specific mechanism is being explored for the first time.

Where this research is happening

  • University of Southern Mississippi
    Hattiesburg, United States
    Active

Researchers

  • Principal investigator: Karim, Shahid — University of Southern Mississippi
  • Study coordinator: Karim, Shahid

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.